Julian J Hopwood-Raja, Alice L Tseng, Nancy L Sheehan, Sharon L Walmsley, Julian Falutz, Alice Zhabokritsky
{"title":"CHANGE-Rx:加拿大65岁及以上艾滋病毒感染者队列中的虚弱、跌倒、多种药物和不适当药物使用。","authors":"Julian J Hopwood-Raja, Alice L Tseng, Nancy L Sheehan, Sharon L Walmsley, Julian Falutz, Alice Zhabokritsky","doi":"10.1097/QAD.0000000000004284","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To characterize the prevalence of polypharmacy, use of potentially inappropriate medications (PIMs), anticholinergic burden (ACB), and sedative burden and their association with the risk of frailty and falls in a Canadian cohort of older people with HIV.</p><p><strong>Design: </strong>CHANGE-Rx is a cross-sectional analysis of baseline data from CHANGE-HIV, a prospective Canadian cohort of people with HIV aged 65 years and older.</p><p><strong>Methods: </strong>Information on prescription, over-the-counter/natural-health product use, comorbidities, HIV-specific factors, frailty, and fall history were assessed at the baseline visit at cohort entry. Proportion of people with polypharmacy (≥5 non-antiretroviral drugs), severe polypharmacy (≥10 non-antiretroviral drugs), PIMs, ACB, and sedative burden were determined. Chi-square tests and multivariate regression analysis were used to assess the association between medication factors and the risk of frailty and falls.</p><p><strong>Results: </strong>Four hundred forty participants were included: median age 69 years (range: 65-89), 16.4% were classified as frail, 20.7% experienced a fall (last 6 months), 53.8% had polypharmacy, 14.6% had severe polypharmacy, 49.3% had at least one 1 PIM. For prescribed comedications, 16.5 and 55.7% of participants had high ACB and sedative burden, respectively. The odds ratios (ORs) for frailty were 3.3, 2.6, and 2.9 among patients with high ACB, high sedative burden, and severe polypharmacy, respectively. The OR for falls were 1.9 and 1.8 for patients with high sedative burden and at least one PIM, respectively.</p><p><strong>Conclusion: </strong>Polypharmacy, PIMs, and high ACB and sedative burden are common among older adults with HIV in Canada. It remains to be determined if interventions addressing polypharmacy/PIMs would reduce falls and frailty.</p>","PeriodicalId":7502,"journal":{"name":"AIDS","volume":" ","pages":"1898-1906"},"PeriodicalIF":3.1000,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CHANGE-Rx: frailty, falls, polypharmacy, and inappropriate medication use in a Canadian cohort of people aged 65 years and older with HIV.\",\"authors\":\"Julian J Hopwood-Raja, Alice L Tseng, Nancy L Sheehan, Sharon L Walmsley, Julian Falutz, Alice Zhabokritsky\",\"doi\":\"10.1097/QAD.0000000000004284\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To characterize the prevalence of polypharmacy, use of potentially inappropriate medications (PIMs), anticholinergic burden (ACB), and sedative burden and their association with the risk of frailty and falls in a Canadian cohort of older people with HIV.</p><p><strong>Design: </strong>CHANGE-Rx is a cross-sectional analysis of baseline data from CHANGE-HIV, a prospective Canadian cohort of people with HIV aged 65 years and older.</p><p><strong>Methods: </strong>Information on prescription, over-the-counter/natural-health product use, comorbidities, HIV-specific factors, frailty, and fall history were assessed at the baseline visit at cohort entry. Proportion of people with polypharmacy (≥5 non-antiretroviral drugs), severe polypharmacy (≥10 non-antiretroviral drugs), PIMs, ACB, and sedative burden were determined. Chi-square tests and multivariate regression analysis were used to assess the association between medication factors and the risk of frailty and falls.</p><p><strong>Results: </strong>Four hundred forty participants were included: median age 69 years (range: 65-89), 16.4% were classified as frail, 20.7% experienced a fall (last 6 months), 53.8% had polypharmacy, 14.6% had severe polypharmacy, 49.3% had at least one 1 PIM. For prescribed comedications, 16.5 and 55.7% of participants had high ACB and sedative burden, respectively. The odds ratios (ORs) for frailty were 3.3, 2.6, and 2.9 among patients with high ACB, high sedative burden, and severe polypharmacy, respectively. The OR for falls were 1.9 and 1.8 for patients with high sedative burden and at least one PIM, respectively.</p><p><strong>Conclusion: </strong>Polypharmacy, PIMs, and high ACB and sedative burden are common among older adults with HIV in Canada. It remains to be determined if interventions addressing polypharmacy/PIMs would reduce falls and frailty.</p>\",\"PeriodicalId\":7502,\"journal\":{\"name\":\"AIDS\",\"volume\":\" \",\"pages\":\"1898-1906\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AIDS\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/QAD.0000000000004284\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/27 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAD.0000000000004284","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
CHANGE-Rx: frailty, falls, polypharmacy, and inappropriate medication use in a Canadian cohort of people aged 65 years and older with HIV.
Objective: To characterize the prevalence of polypharmacy, use of potentially inappropriate medications (PIMs), anticholinergic burden (ACB), and sedative burden and their association with the risk of frailty and falls in a Canadian cohort of older people with HIV.
Design: CHANGE-Rx is a cross-sectional analysis of baseline data from CHANGE-HIV, a prospective Canadian cohort of people with HIV aged 65 years and older.
Methods: Information on prescription, over-the-counter/natural-health product use, comorbidities, HIV-specific factors, frailty, and fall history were assessed at the baseline visit at cohort entry. Proportion of people with polypharmacy (≥5 non-antiretroviral drugs), severe polypharmacy (≥10 non-antiretroviral drugs), PIMs, ACB, and sedative burden were determined. Chi-square tests and multivariate regression analysis were used to assess the association between medication factors and the risk of frailty and falls.
Results: Four hundred forty participants were included: median age 69 years (range: 65-89), 16.4% were classified as frail, 20.7% experienced a fall (last 6 months), 53.8% had polypharmacy, 14.6% had severe polypharmacy, 49.3% had at least one 1 PIM. For prescribed comedications, 16.5 and 55.7% of participants had high ACB and sedative burden, respectively. The odds ratios (ORs) for frailty were 3.3, 2.6, and 2.9 among patients with high ACB, high sedative burden, and severe polypharmacy, respectively. The OR for falls were 1.9 and 1.8 for patients with high sedative burden and at least one PIM, respectively.
Conclusion: Polypharmacy, PIMs, and high ACB and sedative burden are common among older adults with HIV in Canada. It remains to be determined if interventions addressing polypharmacy/PIMs would reduce falls and frailty.
期刊介绍:
Publishing the very latest ground breaking research on HIV and AIDS. Read by all the top clinicians and researchers, AIDS has the highest impact of all AIDS-related journals. With 18 issues per year, AIDS guarantees the authoritative presentation of significant advances. The Editors, themselves noted international experts who know the demands of your work, are committed to making AIDS the most distinguished and innovative journal in the field. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.